Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells

Notch signaling is often and aberrantly activated by hypoxia during tumor progression; however, the exact pathological role of hypoxia-induced Notch signaling in tumor metastasis is as yet poorly understood. In this study, we aimed to define the mechanism of Notch-ligand activation by hypoxia in both primary tumor and bone stromal cells in the metastatic niche and to clarify their roles in tumor progression. We have analyzed the expression profiles of various Notch ligands in 779 breast cancer patients in GEO database and found that the expression of Jagged2 among all five ligands is most significantly correlated with the overall- and metastasis-free survival of breast cancer patients. The results of our immunohistochemical (IHC) analysis for Jagged2 in 61 clinical samples also revealed that both Jagged2 and Notch signaling were strongly upregulated at the hypoxic invasive front. Activation of Jagged2 by hypoxia in tumor cells induced EMT and also promoted cell survival in vitro. Notably, a γ-secretase inhibitor significantly blocked Notch-mediated invasion and survival under hypoxia by promoting expression of E-cadherin and inhibiting Akt phosphorylation. Importantly, Jagged2 was also found to be upregulated in bone marrow stroma under hypoxia and promoted the growth of cancer stem-like cells by activating their Notch signaling. Therefore, hypoxia-induced Jagged2 activation in both tumor invasive front and normal bone stroma has a critical role in tumor progression and metastasis, and Jagged2 is considered to be a valuable prognostic marker and may serve as a novel therapeutic target for metastatic breast cancer.

[1]  S. Liang,et al.  Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway , 2010, Oncogene.

[2]  G. Koren,et al.  Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction , 2008, Stem cells.

[3]  Mi Hyun Kim,et al.  Activation of Notch Signaling in a Xenograft Model of Brain Metastasis , 2008, Clinical Cancer Research.

[4]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[5]  G. Roodman.  Mechanisms of bone metastasis. , 2004, Discovery medicine.

[6]  Zhiwei Wang,et al.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. , 2010, Biochimica et biophysica acta.

[7]  A. Harris,et al.  Necrosis and Hypoxia in Invasive Breast Carcinoma , 2003, Breast Cancer Research and Treatment.

[8]  U. Lendahl,et al.  Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cells. , 2010, Experimental Cell Research.

[9]  Tsonwin Hai,et al.  The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. , 2006, Cancer research.

[10]  N. Davidson,et al.  A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Clarke,et al.  Aberrant Activation of Notch Signaling in Human Breast Cancer , 2006 .

[12]  P. V. van Diest,et al.  The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators. , 2007, Human pathology.

[13]  J. Minna,et al.  Distinct Biological Roles for the Notch Ligands Jagged-1 and Jagged-2* , 2009, The Journal of Biological Chemistry.

[14]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[15]  A. Karsan,et al.  Recent insights into the role of Notch signaling in tumorigenesis. , 2006, Blood.

[16]  U. Lendahl,et al.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.

[17]  A. Gazdar,et al.  Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. , 2007, Cancer research.

[18]  Prashant Mali,et al.  Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. , 2008, Cell stem cell.

[19]  G. Lockwood,et al.  High-level JAG1 mRNA and protein predict poor outcome in breast cancer , 2007, Modern Pathology.

[20]  Y. Mo,et al.  Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. , 2008, Cancer research.

[21]  V. Haase.  Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. , 2009, Kidney international.

[22]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[23]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[24]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[25]  S. Artavanis-Tsakonas,et al.  Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A Gulino,et al.  Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. , 1999, International immunology.

[27]  M. Ohh,et al.  The role of hypoxia-inducible factors in cancer , 2007, Cellular and Molecular Life Sciences.

[28]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[29]  M. Schindl,et al.  Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  N. Yoo,et al.  Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[31]  Ling Lin,et al.  Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation. , 2010, Oncology reports.

[32]  K. Parmar,et al.  Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia , 2007, Proceedings of the National Academy of Sciences.

[33]  P. Cejudo-Martı́n,et al.  A new notch in the HIF belt: how hypoxia impacts differentiation. , 2005, Developmental cell.

[34]  G. Weinmaster,et al.  Canonical and non-canonical Notch ligands. , 2010, Current topics in developmental biology.

[35]  L. Allen.  Stem cells. , 2003, The New England journal of medicine.

[36]  M. Mullendore,et al.  Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer , 2009, Clinical Cancer Research.

[37]  F. Radtke,et al.  Notch and cancer: a double-edged sword , 2008, Cellular and Molecular Life Sciences.

[38]  S. Artavanis-Tsakonas,et al.  Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. , 2004, The American journal of pathology.

[39]  A. Giaccia,et al.  Notch1 is an effector of Akt and hypoxia in melanoma development. , 2008, The Journal of clinical investigation.

[40]  G. Lockwood,et al.  High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. , 2005, Cancer research.

[41]  Hua Zhang,et al.  The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma. , 2010, Oncology reports.

[42]  K. Olive,et al.  Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model. , 2009, Cancer research.

[43]  Linheng Li,et al.  The stem cell niches in bone. , 2006, The Journal of clinical investigation.

[44]  P. Lambin,et al.  Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours. , 1998, Anaerobe.

[45]  Leonard I Zon,et al.  Cell stem cell. , 2007, Cell stem cell.